| Financial Year |
March 31 2023 |
| Monetary Funds |
424,040,361.72 |
| Held-for-trading Financial Assets |
30,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,281,628,164.66 |
| Advances to Suppliers |
373,756,892.66 |
| Other Receivables |
72,725,823.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,080,912.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,624,560.43 |
| Total Current Assets |
2,342,276,776.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
83,511,439.28 |
| Investment Properties |
-- |
| Fixed Assetes |
3,486,812.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,843,461.79 |
| R&D expenses |
-- |
| Goodwill |
18,601,227.44 |
| Long-Term Deferred and Prepaid Expenses |
30,676,233.04 |
| Deferred Income Tax Assets |
27,190,472.09 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
281,073,989.83 |
| Total Assets |
2,623,350,766.49 |
| Short-Term Loans |
400,222,075.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
191,810,639.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,295,112.54 |
| Taxes Payable |
12,588,885.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,858,185.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,102,087.07 |
| Other Current Liabilities |
56,279,339.84 |
| Sub-Total of Current Liabilities |
950,414,016.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,490,363.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,352,767.83 |
| Total Liabilities |
1,017,766,783.93 |
| Paid-In Capital(Or Share Stock) |
544,276,198.00 |
| Capital Surplus |
1,646,884,890.96 |
| Surplus Reserve |
75,695,657.38 |
| LESS:Treasury Stock |
10,680,400.00 |
| Undistributed Profits |
-704,986,592.14 |
| Minority Stockholder's Interest |
46,923,137.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,558,660,845.42 |
| Owner's Equity（Stockholder's Equity） |
1,605,583,982.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,623,350,766.49 |
